CompletedNot Applicable

Vital Pulp Therapy of Mature Permanent Teeth With Irreversible Pulpitis Using Bioceramic Material

Egypt40 participantsStarted 2022-12-01

Plain-language summary

This clinical trial is designed to study and compare the effect of two different types of chelating agents on the vital pulp therapy of mature permanent teeth with irreversible pulpitis using bioceramic material.

Who can participate

Age range18 Years – 50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Presence of at least one tooth with carious pulp exposure and irreversible pulpitis. * Cooperative behavior with no medical problem. * Absence of tooth mobility , tenderness on percussion. * History of pain with cold and sweets. * Radiographically, no internal or external resorption, no periapical or furcation radiolucency and no widening of the periodontal membrane space. Exclusion Criteria: * Teeth with pulp necrosis. * Presence of sinus tract. * Teeth with open apices. * Pregnant women. * History of intolerance of non- steroidal anti inflammatory drugs. * Tenderness to palpation of adjacent soft tissues

What they're measuring

Success rate of vital pulp therapy of mature permanent teeth with irreversible pulpitis using bioceramic material.

Timeframe: one year

The Pulp vitality

Timeframe: one year

Trial details

NCT IDNCT05970536

SponsorSinai University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-12-01

View on ClinicalTrials.gov More Vital Pulp Therapy trials